Which standard transthoracic (TTE) and transesophageal (TEE) echocardiographic views are used to measure the tricuspid valve annulus (≥40 mm on TTE) and intercommissural distance (≥70 mm on TEE), and how can the commissures, leaflets, and subvalvular apparatus be visualized?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Echocardiographic Visualization of the Tricuspid Valve: Standard Views and Measurements

For TTE, measure the tricuspid annulus in the apical 4-chamber view where ≥40 mm (or >21 mm/m²) indicates significant dilatation; for TEE, the intercommissural distance of ≥70 mm is measured directly during surgery, not routinely on TEE imaging. 1, 2, 3

TTE Standard Views for Tricuspid Valve Assessment

The tricuspid valve is visualized using three main TTE approaches 1:

Primary Views:

  • Apical 4-chamber view - This is the most feasible (92% success rate) and reproducible view for measuring the tricuspid annulus diameter 1, 4

    • Measure the annulus in diastole from this view
    • Normal diameter: 28 ± 5 mm
    • Significant dilatation: >40 mm or >21 mm/m² 1, 2, 3
  • Parasternal long-axis RV inflow view - Shows the anterior and septal leaflets

  • Parasternal short-axis at aortic valve level - Provides cross-sectional view of the valve

  • Subcostal view - The only view where all three leaflets can occasionally be visualized simultaneously (though rarely achieved) 1

Important Caveat:

2D TTE systematically underestimates annular dimensions by approximately 4 mm compared to 3D measurements 4, 5. Despite this, the apical 4-chamber view remains the guideline-recommended standard because it offers the highest feasibility and reproducibility 1, 4.

TEE Standard Views for Tricuspid Valve Assessment

TEE visualization is more limited for the tricuspid valve 1:

Primary TEE View:

  • Mid-esophageal 4-chamber view at 0 degrees - Obtained from basal transesophageal or esophagogastric junction planes 1

    • This view allows assessment of leaflet morphology and regurgitation
    • Can measure annular diameter, though transgastric views are more accurate 6
  • Transgastric RV inflow/outflow view - Provides the most accurate correlation with surgical measurements (r=0.98) 6

The 70 mm Intercommissural Distance:

This measurement is NOT routinely obtained on TEE imaging - it refers to direct intraoperative measurement by the surgeon during open cardiac surgery 2. The guidelines reference "≥70 mm on direct intraoperative measurement" as a criterion for prophylactic tricuspid annuloplasty, not as a TEE-derived parameter.

Visualizing Commissures, Leaflets, and Subvalvular Apparatus

2D Limitations:

It is rarely possible to visualize all three leaflets simultaneously with 2D echocardiography 1. Therefore, leaflet designation should be done cautiously unless all three cusps are seen together (occasionally possible from modified subcostal view) 1.

Leaflet Anatomy and Identification:

The three leaflets are 1:

  • Anterior leaflet - Largest; extends from infundibular region to inferolateral wall
  • Septal leaflet - Extends from interventricular septum to posterior ventricular border; inserts more apically than the mitral valve
  • Posterior leaflet - Attaches along posterior annular margin from septum to inferolateral wall

3D Echocardiography - The Superior Approach:

Real-time 3D TTE is the optimal method for comprehensive tricuspid valve assessment 1, 7:

  • Provides short-axis "en-face" views of the tricuspid valve showing all three leaflets simultaneously during the cardiac cycle 1
  • Visualizes commissures and their attachment to the annulus 1
  • Shows spatial relationships between leaflets and surrounding structures 7
  • Can be obtained from both ventricular perspective (looking up from RV) and atrial perspective (surgical view looking down) 7

Subvalvular Apparatus Assessment:

From the apical 4-chamber view, evaluate 1:

  • Tethering - Measure systolic tenting area (area between annulus and leaflet bodies) and coaptation distance in mid-systole
    • Tenting area >1 cm² indicates severe tethering associated with severe TR 1
    • Coaptation distance >0.76 cm predicts residual TR after annuloplasty 1
  • Papillary muscle position - Assess for displacement
  • Chordal attachments - Best seen with 3D imaging 7

Practical Algorithm for Tricuspid Valve Assessment

  1. Start with TTE apical 4-chamber view:

    • Measure annular diameter in diastole
    • Assess leaflet coaptation and tethering
    • Measure tenting area if TR present
  2. Add parasternal and subcostal views:

    • Attempt to identify individual leaflets
    • Assess RV size and function
  3. If surgical planning or detailed anatomy needed:

    • Obtain 3D TTE for comprehensive leaflet and commissural visualization
    • Consider TEE (transgastric views) if TTE windows inadequate 6
  4. Reserve TEE primarily for:

    • Endocarditis evaluation
    • Lead/catheter complications
    • Traumatic rupture
    • Transcatheter intervention guidance 1

Key Measurement Pitfall:

Do not confuse the 40 mm TTE cutoff with the 70 mm surgical measurement - these are different parameters measured in different contexts. The 40 mm is a 2D TTE measurement from apical 4-chamber view; the 70 mm is a direct surgical measurement of the intercommissural distance during open surgery 2, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.